Telmisartan and Amlodipine

Lupin Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Dec 15, 2023
Approval ID: a97fefa6-99e6-4eb7-9393-ab2252a2c7d8
Products: 4 registered
Version: 10

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TELMISARTAN AND AMLODIPINE TABLETS safely and effectively. See full prescribing information for TELMISARTAN AND AMLODIPINE TABLETS.TELMISARTAN and AMLODIPINE tablets, for oral useInitial U.S. Approval: 2009

Quick Stats

Total Products4

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.